These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7375203)

  • 1. [Use of hyperimmune serum with anti-HBsAg antibodies for the treatment of hepatic encephalopathy in viral hepatitis in an infant].
    Taraszkiewicz F; Kurpios J; Kaczmarski M
    Pediatr Pol; 1980 Feb; 55(2):229-32. PubMed ID: 7375203
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of hepatic coma due to fulminant viral hepatitis B using anti-HB plasma].
    Baumann W; Hanisch M; Emmrich P; Arnold W
    Monatsschr Kinderheilkd (1902); 1978 May; 126(5):335-7. PubMed ID: 651929
    [No Abstract]   [Full Text] [Related]  

  • 3. Different antibody responses against hepatitis B surface antigen among mouse strains transfected with mutant viral DNA.
    Hasegawa K; Joh R; Iizuka A; Naritomi T; Kanai N; Ogawa M; Torii N; Hayashi N
    J Gastroenterol; 2002; 37(12):1035-41. PubMed ID: 12522535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe vaccination against hepatitis B virus and discontinuation of hepatitis B immune globulin treatment in a liver transplanted patient.
    Weiss P
    Transplant Proc; 2000 Jun; 32(4):712-3. PubMed ID: 10856555
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary transplant treatment of hepatitis B: hepatitis B immunoglobulin (passive immunization).
    Pruett T
    Liver Transpl Surg; 1997 Sep; 3(5 Suppl 1):S13-5. PubMed ID: 9377765
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-HBs immunoglobulin].
    Poszwiński P; Kacperska E; Głoskowska-Moraczewska Z; Seyfried H
    Pol Tyg Lek; 1979 Nov; 34(46):1789-91. PubMed ID: 545318
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunocorrective therapy of severe forms of hepatitis B].
    Arkhipov GS; Shabalin VV; Makarova TA; Trug AD; Khriapov BT
    Ter Arkh; 1985; 57(10):94-7. PubMed ID: 3878605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of chronic HBsAg carriership in infants of HBsAg-positive mothers by hepatitis B immunoglobulin.
    Reesink HW; Reesink-Brongers EE; Lafeber-Schut BJ; Kalshoven-Benschop J; Brummelhuis HG
    Acta Haematol Pol; 1980; 11(2):79-81. PubMed ID: 7424485
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of passively administered antibody to hepatitis B surface antigen to augment the immune response of a low-responder population to hepatitis B vaccination.
    Minuk GY; German GB; Bernstein KN; Fine A; Schroeder ML; Wong WW
    Clin Invest Med; 1994 Feb; 17(1):61-5. PubMed ID: 8174316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B surface antigen and antibody among hospital admitted patients in Manipal.
    Dutta S; Shivananda PG; Chatterjee A
    Indian J Public Health; 1994; 38(3):108-12. PubMed ID: 7774971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exchange-blood transfusion in the treatment of hepatic coma due to fulminating serum hepatitis.
    Besselaar GH; Loeliger EA; Fekkes N; Eernisse G
    Folia Med Neerl; 1966 Nov; 9(5):160-3. PubMed ID: 5979186
    [No Abstract]   [Full Text] [Related]  

  • 14. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC; Yuan JM; Ross RK; Govindarajan S
    Hepatology; 1997 Jan; 25(1):226-8. PubMed ID: 8985295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some observations on tattooing and the incidence of HBsAg and anti-HBs in the population (author's transl)].
    Maretić Z; Jerin L; Raguz-Milotić V
    Lijec Vjesn; 1981; 103(2-3):53-4. PubMed ID: 7311699
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prevention of recurrent hepatitis B virus after liver transplantation.
    Ilan Y; Eid A; Tur-Kaspa R
    Isr J Med Sci; 1995 Aug; 31(8):469-73. PubMed ID: 7635695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laser therapy of acute hepatic encephalopathy in patients with hepatitis B].
    Botsvadze ES; Katsitadze TK; Okrostsvaridze NI; Zaldastanishvili MP; Kvitashvili MA
    Klin Med (Mosk); 1996; 74(4):69. PubMed ID: 8999166
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of quantitative indicators of HBsAg in the pathogenesis and outcome of a malignant form of viral hepatitis B in children].
    Nisevich NI; Zubikova II; Chaplygina GV; Romaniukha AA; Konev VA
    Pediatriia; 1989; (7):14-20. PubMed ID: 2780156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.